Fresh Day Meds Review
Best for: Price-sensitive patients seeking the lowest-cost compounded semaglutide or tirzepatide from a LegitScript-certified, HIPAA-compliant multi-product telehealth platform with publicly disclosed Texas corporate headquarters, who don't require a named pharmacy partner or brand-name GLP-1 fallback.
Fresh Day Meds (freshdaymeds.com) is a Houston, Texas-based multi-product telehealth platform — operated by Fresh Day Meds, LLC with medical group partner Telegra MD LLC (Spokane, WA) — offering compounded semaglutide ($133-$160/mo) and compounded tirzepatide ($166-$199/mo) alongside hair (finasteride, minoxidil), sexual wellness (sildenafil, tadalafil), testosterone (enclomiphene), and daily wellness (NAD+, MIC+B12) products. LegitScript-certified and HIPAA-compliant; ships from state-licensed 503A/503B compounding pharmacies (partner not publicly named). No brand-name GLP-1s offered; consultation fee is bundled (no separate charge); free expedited shipping with prescription in under 4 hours.
High confidence · Last verified 2026-05-15 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Fresh Day Meds is one of the most affordable GLP-1 options on the market.
Score Breakdown
Drugs Offered
Fresh Day Meds prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| All doses (3-mo bundle, $399 billed) | compounded | $133 |
| All doses (1-mo) | compounded | $160 |
| All doses (3-mo bundle, $499 billed) | compounded | $166 |
| All doses (1-mo) | compounded | $199 |
✓ Pros
- •Among the lowest compounded GLP-1 pricing in the market ($133/mo semaglutide, $166/mo tirzepatide on 3-mo bundle)
- •LegitScript certified and HIPAA compliant — verified third-party trust signals
- •All 50 states + DC coverage per About page (49 states + DC explicitly enumerated in ToS)
- •Free expedited shipping with prescription review in <4 hours
- •No membership or consultation fees stacked on top of medication price
- •Multi-product platform — single account covers GLP-1, hair, sexual wellness, TRT, NAD+/B12
- •Houston, TX corporate headquarters publicly disclosed (7803 Hansen Rd Ste B)
✗ Cons
- •Compounding pharmacy partner not named publicly — only 'state-licensed 503A/503B compounding pharmacies' disclosed
- •Medical director and founder names not disclosed on public site or About page
- •No brand-name GLP-1 fallback (Wegovy/Ozempic/Zepbound/Mounjaro) — compounded-only model exposes patients if FDA ends the shortage exemption pathway
- •Verbatim ToS state list enumerates 49 states + DC (Arkansas omitted) while About page claims 'all 50 states + DC' — minor inconsistency
- •Dose-specific milligram pricing not displayed on product pages — only flat 'as low as' pricing visible pre-checkout
- •Medical group operates as Telegra MD LLC (Spokane, WA) — typical white-label PC arrangement common in telehealth compounded GLP-1 sector
Ready to start with Fresh Day Meds?
Starting at $133/month. See current pricing and start your free consultation.
Sources & methodology
Our Fresh Day Meds review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Fresh Day Meds
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Fresh Day Meds?
Starting at $133/month. See current pricing and start your free consultation.